These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32184670)

  • 1. Telomere Length in Renal Cell Carcinoma: The Jekyll and Hyde Biomarker of Ageing of the Kidney.
    Morais M; Dias F; Teixeira AL; Medeiros R
    Cancer Manag Res; 2020; 12():1669-1679. PubMed ID: 32184670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis.
    Matsuda Y; Ye J; Yamakawa K; Mukai Y; Azuma K; Wu L; Masutomi K; Yamashita T; Daigo Y; Miyagi Y; Yokose T; Oshima T; Ito H; Morinaga S; Kishida T; Minamoto T; Kojima M; Kaneko S; Haba R; Kontani K; Kanaji N; Okano K; Muto-Ishizuka M; Yokohira M; Saoo K; Imaida K; Suizu F
    J Natl Cancer Inst; 2023 Feb; 115(2):208-218. PubMed ID: 36567450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.
    Machiela MJ; Hofmann JN; Carreras-Torres R; Brown KM; Johansson M; Wang Z; Foll M; Li P; Rothman N; Savage SA; Gaborieau V; McKay JD; Ye Y; Henrion M; Bruinsma F; Jordan S; Severi G; Hveem K; Vatten LJ; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Freeman LEB; Koutros S; Albanes D; Mannisto S; Weinstein S; Clark PE; Edwards TE; Lipworth L; Gapstur SM; Stevens VL; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Gaziano JM; Sesso HS; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Colli LM; Sampson JN; Besse C; Blanche H; Boland A; Burdette L; Prokhortchouk E; Skryabin KG; Yeager M; Mijuskovic M; Ognjanovic M; Foretova L; Holcatova I; Janout V; Mates D; Mukeriya A; Rascu S; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Szeszenia-Dabrowska N; Benhamou S; Cancel-Tassin G; Cussenot O; Bueno-de-Mesquita HB; Canzian F; Duell EJ; Ljungberg B; Sitaram RT; Peters U; White E; Anderson GL; Johnson L; Luo J; Buring J; Lee IM; Chow WH; Moore LE; Wood C; Eisen T; Larkin J; Choueiri TK; Lathrop GM; Teh BT; Deleuze JF; Wu X; Houlston RS; Brennan P; Chanock SJ; Scelo G; Purdue MP
    Eur Urol; 2017 Nov; 72(5):747-754. PubMed ID: 28797570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma.
    Zheng X; Wezel F; Azoitei A; Meessen S; Wang W; Najjar G; Wang X; Kraus JM; Kestler HA; John A; Zengerling F; Bolenz C; Günes C
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma.
    Park JY; Luu HN; Park HY; Lin HY; Radlein S; Di Pietro G; Yeo CD; Kim SJ; Kang N; Antwi S; Sexton WJ; Spiess PE; Dickinson S; Parker A
    Transl Cancer Res; 2019 Jul; 8(Suppl 4):S397-S403. PubMed ID: 35117117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented telomerase activity, reduced telomere length and the presence of alternative lengthening of telomere in renal cell carcinoma: plausible predictive and diagnostic markers.
    Pal D; Sharma U; Khajuria R; Singh SK; Kakkar N; Prasad R
    Gene; 2015 May; 562(2):145-51. PubMed ID: 25769384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere length in relation to immunological parameters in patients with renal cell carcinoma.
    Svenson U; Grönlund E; Söderström I; Sitaram RT; Ljungberg B; Roos G
    PLoS One; 2013; 8(2):e55543. PubMed ID: 23383336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Accelerated telomere erosion in schizophrenia: A literature review].
    Corfdir C; Pignon B; Szöke A; Schürhoff F
    Encephale; 2021 Aug; 47(4):369-375. PubMed ID: 33863507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of water, sanitation, handwashing, and nutritional interventions on telomere length among children in a cluster-randomized controlled trial in rural Bangladesh.
    Lin A; Arnold BF; Mertens AN; Lin J; Benjamin-Chung J; Ali S; Hubbard AE; Stewart CP; Shoab AK; Rahman MZ; Hossen MS; Mutsuddi P; Famida SL; Akther S; Rahman M; Unicomb L; Dhabhar FS; Fernald LCH; Colford JM; Luby SP
    Elife; 2017 Oct; 6():. PubMed ID: 28980942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study.
    Hofmann JN; Baccarelli A; Schwartz K; Davis FG; Ruterbusch JJ; Hoxha M; McCarthy BJ; Savage SA; Wacholder S; Rothman N; Graubard BI; Colt JS; Chow WH; Purdue MP
    Br J Cancer; 2011 Nov; 105(11):1772-5. PubMed ID: 22033273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere Attrition in Chronic Kidney Diseases.
    Levstek T; Trebušak Podkrajšek K
    Antioxidants (Basel); 2023 Feb; 12(3):. PubMed ID: 36978826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts.
    Ha M; Jeong H; Roh JS; Lee B; Han ME; Oh SO; Sohn DH; Kim YH
    Urol Oncol; 2019 Oct; 37(10):735-741. PubMed ID: 31377166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Telomere Length, Chronic Kidney Disease, and Renal Traits: A Systematic Review.
    Ameh OI; Okpechi IG; Dandara C; Kengne AP
    OMICS; 2017 Mar; 21(3):143-155. PubMed ID: 28253088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in telomere lengths in renal cell carcinomas.
    Dahse R; Fiedler W; Ernst G; Kosmehl H; Schlichter A; Schubert J; Claussen U
    Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):477-85. PubMed ID: 8828903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology.
    de Martino M; Taus C; Lucca I; Hofbauer SL; Haitel A; Shariat SF; Klatte T
    Mol Carcinog; 2016 Oct; 55(10):1458-66. PubMed ID: 26294352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of telomere length as a predictive biomarker for injury prognosis in juvenile rats following a concussion/mild traumatic brain injury.
    Hehar H; Mychasiuk R
    Neurobiol Dis; 2016 Mar; 87():11-8. PubMed ID: 26709201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
    Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
    Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.
    Martinez-Delgado B; Gallardo M; Tanic M; Yanowsky K; Inglada-Perez L; Barroso A; Rodriguez-Pinilla M; Cañamero M; Blasco MA; Benitez J
    Breast Cancer Res Treat; 2013 Sep; 141(2):231-42. PubMed ID: 24036693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.